GlaxoSmithKline faces sales decline in a three month period Cuson
YOUR PRIVACY - PLEASE READ CAREFULLY DATA PROTECTION STATEMENT
Below we explain how we will communicate with you. We set out how we use your data in our Privacy Policy.
Global City Media, and its associated brands will use the lawful basis of legitimate interests to use
the
contact details you have supplied to contact you regarding our publications, events, training,
reader
research, and other relevant information. We will always give you the option to opt out of our
marketing.
By clicking submit, you confirm that you understand and accept the Terms & Conditions and Privacy Policy
The decline was described as 'disappointing' by the chief executive, Sir Andrew Witty, who pointed to the scandal as an important reason why customers took their business elsewhere. Glaxo has admitted that some of its personnel might have broken laws. The Chinese police have claimed that up to the equivalent of £300 million may have been used to bribe doctors with regards to Glaxo pharmaceutical products.
Too early to predict
Commenting on the issue, Sir Andrew said that it was 'too early' to predict the likely cost of total fines, according to The Financial Times. He added that 'our legal position is where it should be at this stage'.
Email your news and story ideas to: [email protected]
Copyright 2024 © The Global Legal Post. All Rights Reserved
